COVID Vaccine Maker Cuts Revenue Projections Due to Drop in Demand

Pfizer partner BioNTech projects making less money from COVID-19 vaccines.

BioNTech CEO Ugur Sahin in Rwanda in a file photo. Luke Dray/Getty Images

Pfizer partner BioNTech is projecting that it will make less money than previously expected from COVID-19 vaccines.

BioNTech now projects that it will make about $4 billion from the shots this year, down from a projection earlier this year of $5 billion.